We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.37%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$24.3B
AUM Growth
+$757M
(+3.2%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-4.28%
Top 10 Holdings %
Top 10 Hldgs %
26.42%
Holding
1,541
New
37
Increased
296
Reduced
731
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$74.9M |
| 2 |
Verizon
VZ
|
+$67.6M |
| 3 |
T-Mobile US
TMUS
|
+$55.1M |
| 4 |
Aflac
AFL
|
+$49.5M |
| 5 |
MRSH
Marsh
MRSH
|
+$47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$392M |
| 2 |
NVIDIA
NVDA
|
+$164M |
| 3 |
Microsoft
MSFT
|
+$93.5M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$72.3M |
| 5 |
IBM
IBM
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.54% |
| 2 | Healthcare | 18.94% |
| 3 | Financials | 12.78% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Communication Services | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CVS Health
CVS
$134B
| $67M | 0.28% |
968,972
-239,094
| -20% | -$17M |
|
77
Chubb
CB
$134B
| $65.7M | 0.27% |
341,251
+71,753
| +27% | +$14.1M |
|
78
Agilent Technologies
A
$39.5B
| $65.3M | 0.27% |
542,771
-31,148
| -5% | -$3.97M |
|
79
Medtronic
MDT
$111B
| $64.4M | 0.26% |
730,621
-361,773
| -33% | -$31.1M |
|
|
80
T-Mobile US
TMUS
$190B
| $64.2M | 0.26% |
462,547
+392,475
| +560% | +$55.1M |
|
81
Xylem
XYL
$27.8B
| $64.2M | 0.26% |
569,894
-33,188
| -6% | -$3.51M |
|
82
Ecolab
ECL
$78.6B
| $63.5M | 0.26% |
340,292
+39,338
| +13% | +$6.77M |
|
83
AT&T
T
$162B
| $62.9M | 0.26% |
3,942,067
+2,144,740
| +119% | +$36.5M |
|
84
Moody's
MCO
$83.7B
| $62.4M | 0.26% |
179,310
-922
| -0.5% | -$292K |
|
85
Fortinet
FTNT
$120B
| $61.7M | 0.25% |
815,935
+223,370
| +38% | +$15.2M |
|
86
Humana
HUM
$45B
| $60.8M | 0.25% |
135,942
-770
| -0.6% | -$388K |
|
87
DexCom
DXCM
$32.9B
| $60.5M | 0.25% |
471,074
+11,170
| +2% | +$1.35M |
|
88
Lam Research
LRCX
$369B
| $59.6M | 0.25% |
927,600
-113,930
| -11% | -$6.42M |
|
89
PNC Financial Services
PNC
$100B
| $59.5M | 0.24% |
472,421
+189,297
| +67% | +$23.1M |
|
|
VMW
90
DELISTED
VMware, Inc
VMW
| $58.6M | 0.24% |
407,879
-26,892
| -6% | -$3.49M |
|
91
KLA
KLAC
$239B
| $58.1M | 0.24% |
1,197,850
+176,460
| +17% | +$7.37M |
|
92
Citigroup
C
$224B
| $57.7M | 0.24% |
1,253,126
+219,474
| +21% | +$10.3M |
|
93
Waste Management
WM
$90.5B
| $57.4M | 0.24% |
331,169
-17,726
| -5% | -$2.93M |
|
94
Becton Dickinson
BDX
$46.9B
| $56.2M | 0.23% |
212,929
-1,475
| -0.7% | -$375K |
|
95
Keysight
KEYS
$55B
| $55M | 0.23% |
328,156
+137,569
| +72% | +$21.3M |
|
96
MetLife
MET
$62B
| $54.1M | 0.22% |
957,590
-174,802
| -15% | -$9.7M |
|
97
Morgan Stanley
MS
$332B
| $51.6M | 0.21% |
604,788
-324,436
| -35% | -$27.7M |
|
98
Pentair
PNR
$10.7B
| $51.6M | 0.21% |
798,264
+5,527
| +0.7% | +$318K |
|
99
Idexx Laboratories
IDXX
$44.8B
| $51.3M | 0.21% |
102,046
-3,497
| -3% | -$1.68M |
|
100
Regeneron Pharmaceuticals
REGN
$78.2B
| $51.2M | 0.21% |
71,315
-4,531
| -6% | -$3.49M |
|
Similar funds
HF
KBC Group's Q2 2023 Portfolio in Review
As of Q2 2023, KBC Group held 1,541 positions worth $24.3B, up 3.2% from $23.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
KBC Group withdrew a net $1.04B in Q2 2023, closing 60 positions and reducing 731 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $49.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.
Against the trend, KBC Group opened a new position in Graco worth $12M.
- KBC Group's largest Q2 2023 buy was Graco: 139,329 shares worth $12M.
- KBC Group added most to Johnson & Johnson in Q2 2023, an estimated $74.9M increase.
- KBC Group's biggest Q2 2023 reduction was Apple, cutting an estimated $392M.
- KBC Group fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $49.2M.
- KBC Group's ten largest holdings make up 26% of its $24.3B portfolio in Q2 2023.
- KBC Group opened 37 new positions and closed 60 in Q2 2023.
- KBC Group's portfolio value rose 3.2% quarter-over-quarter to $24.3B.
Based on KBC Group's 13F filing for Q2 2023, filed 28 Jul 2023.